To compare clinical parameters of patients treated with botulinum toxin type A (BTX) for treatment of idiopathic cervical dystonia (ICD) and for tardive cervical dystonia (TCD), we studied 156 patients (149 with ICD and 7 with TCD) who were treated with serial injections of BTX over 5 years. We hypo
Secondary dystonia in a Botulinum Toxin Clinic: Clinical characteristics, neuroanatomical substrate and comparison with idiopathic dystonia
β Scribed by Scott Strader; Robert L. Rodnitzky; Pedro Gonzalez-Alegre
- Book ID
- 116821046
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 310 KB
- Volume
- 17
- Category
- Article
- ISSN
- 1353-8020
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Seventyβsix consecutive patients with cervical dystonia (CD) treated with botulinum toxin were assessed with the Tsui rating scale, the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS), and a global scale of improvement. Tsui, TWSTRS, and TWSTRS subscale scores all showed sig
## Abstract Intramuscular injection of botulinum toxin type A is the treatment of choice for most cases of oromandibular dystonia. We report on five patients with oromandibular dystonia that developed secondary nonresponsiveness to botulinum toxin type A following multiple injections over a 6βyear
Idiopathic torsion dystonia is characterized by involuntary twisting movements and postures. One molecularly defined form with generalized dystonia has been shown to be autosomal dominantly inherited with reduced penetrance in chromosome 9q34.1, especially in Ashkenazi Jewish families, while other g